Reply to: Anti-FXa Activity with Intermediate Dose Thromboprophylaxis in COVID-19. Dutt T, Simcox D, Downey C, McLenaghan D, et al. Am J Respir Crit Care Med 2020 Sep 15. doi: 10.1164/rccm.202007-2913.

Read + Share

Amedeo Smart

Independent Medical Education

Dutt T, Simcox D, Downey C, McLenaghan D, et al. Reply to: Anti-FXa Activity with Intermediate Dose Thromboprophylaxis in COVID-19. Am J Respir Crit Care Med 2020 Sep 15. doi: 10.1164/rccm.202007-2913.
PMID: 32931711